List of Table

List of Tables
Table 1. Global Molecular Diagnostics in Point of Care Market Size Growth Rate by Type (US$ Million): 2017 VS 2021 VS 2028
Table 2. Key Players of Polymerase Chain Reaction
Table 3. Key Players of In Situ Hybridization
Table 4. Key Players of Gene Chips
Table 5. Key Players of Next Generation Sequencing
Table 6. Global Molecular Diagnostics in Point of Care Market Size Growth by Application (US$ Million): 2017 VS 2021 VS 2028
Table 7. Global Molecular Diagnostics in Point of Care Market Size by Region (US$ Million): 2017 VS 2021 VS 2028
Table 8. Global Molecular Diagnostics in Point of Care Market Size by Region (2017-2022) & (US$ Million)
Table 9. Global Molecular Diagnostics in Point of Care Market Share by Region (2017-2022)
Table 10. Global Molecular Diagnostics in Point of Care Forecasted Market Size by Region (2023-2028) & (US$ Million)
Table 11. Global Molecular Diagnostics in Point of Care Market Share by Region (2023-2028)
Table 12. Molecular Diagnostics in Point of Care Market Trends
Table 13. Molecular Diagnostics in Point of Care Market Drivers
Table 14. Molecular Diagnostics in Point of Care Market Challenges
Table 15. Molecular Diagnostics in Point of Care Market Restraints
Table 16. Global Molecular Diagnostics in Point of Care Revenue by Players (2017-2022) & (US$ Million)
Table 17. Global Molecular Diagnostics in Point of Care Market Share by Players (2017-2022)
Table 18. Global Top Molecular Diagnostics in Point of Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Point of Care as of 2021)
Table 19. Ranking of Global Top Molecular Diagnostics in Point of Care Companies by Revenue (US$ Million) in 2021
Table 20. Global 5 Largest Players Market Share by Molecular Diagnostics in Point of Care Revenue (CR5 and HHI) & (2017-2022)
Table 21. Key Players Headquarters and Area Served
Table 22. Key Players Molecular Diagnostics in Point of Care Product Solution and Service
Table 23. Date of Enter into Molecular Diagnostics in Point of Care Market
Table 24. Mergers & Acquisitions, Expansion Plans
Table 25. Global Molecular Diagnostics in Point of Care Market Size by Type (2017-2022) & (US$ Million)
Table 26. Global Molecular Diagnostics in Point of Care Revenue Market Share by Type (2017-2022)
Table 27. Global Molecular Diagnostics in Point of Care Forecasted Market Size by Type (2023-2028) & (US$ Million)
Table 28. Global Molecular Diagnostics in Point of Care Revenue Market Share by Type (2023-2028)
Table 29. Global Molecular Diagnostics in Point of Care Market Size by Application (2017-2022) & (US$ Million)
Table 30. Global Molecular Diagnostics in Point of Care Revenue Market Share by Application (2017-2022)
Table 31. Global Molecular Diagnostics in Point of Care Forecasted Market Size by Application (2023-2028) & (US$ Million)
Table 32. Global Molecular Diagnostics in Point of Care Revenue Market Share by Application (2023-2028)
Table 33. North America Molecular Diagnostics in Point of Care Market Size by Country (2017-2022) & (US$ Million)
Table 34. North America Molecular Diagnostics in Point of Care Market Size by Country (2023-2028) & (US$ Million)
Table 35. Europe Molecular Diagnostics in Point of Care Market Size by Country (2017-2022) & (US$ Million)
Table 36. Europe Molecular Diagnostics in Point of Care Market Size by Country (2023-2028) & (US$ Million)
Table 37. Asia-Pacific Molecular Diagnostics in Point of Care Market Size by Region (2017-2022) & (US$ Million)
Table 38. Asia-Pacific Molecular Diagnostics in Point of Care Market Size by Region (2023-2028) & (US$ Million)
Table 39. Latin America Molecular Diagnostics in Point of Care Market Size by Country (2017-2022) & (US$ Million)
Table 40. Latin America Molecular Diagnostics in Point of Care Market Size by Country (2023-2028) & (US$ Million)
Table 41. Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Country (2017-2022) & (US$ Million)
Table 42. Middle East & Africa Molecular Diagnostics in Point of Care Market Size by Country (2023-2028) & (US$ Million)
Table 43. Abbott Company Detail
Table 44. Abbott Business Overview
Table 45. Abbott Molecular Diagnostics in Point of Care Product
Table 46. Abbott Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 47. Abbott Recent Development
Table 48. Accelerate Diagnostics Company Detail
Table 49. Accelerate Diagnostics Business Overview
Table 50. Accelerate Diagnostics Molecular Diagnostics in Point of Care Product
Table 51. Accelerate Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 52. Accelerate Diagnostics Recent Development
Table 53. Ador Diagnostics Company Detail
Table 54. Ador Diagnostics Business Overview
Table 55. Ador Diagnostics Molecular Diagnostics in Point of Care Product
Table 56. Ador Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 57. Ador Diagnostics Recent Development
Table 58. Beckman Coulter Company Detail
Table 59. Beckman Coulter Business Overview
Table 60. Beckman Coulter Molecular Diagnostics in Point of Care Product
Table 61. Beckman Coulter Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 62. Beckman Coulter Recent Development
Table 63. Becton, Dickinson and Company Company Detail
Table 64. Becton, Dickinson and Company Business Overview
Table 65. Becton, Dickinson and Company Molecular Diagnostics in Point of Care Product
Table 66. Becton, Dickinson and Company Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 67. Becton, Dickinson and Company Recent Development
Table 68. Binx Health Company Detail
Table 69. Binx Health Business Overview
Table 70. Binx Health Molecular Diagnostics in Point of Care Product
Table 71. Binx Health Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 72. Binx Health Recent Development
Table 73. Biocartis Company Detail
Table 74. Biocartis Business Overview
Table 75. Biocartis Molecular Diagnostics in Point of Care Product
Table 76. Biocartis Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 77. Biocartis Recent Development
Table 78. bioM?(C)rieux Company Detail
Table 79. bioM?(C)rieux Business Overview
Table 80. bioM?(C)rieux Molecular Diagnostics in Point of Care Product
Table 81. bioM?(C)rieux Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 82. bioM?(C)rieux Recent Development
Table 83. Bio-Rad Laboratories Company Detail
Table 84. Bio-Rad Laboratories Business Overview
Table 85. Bio-Rad Laboratories Molecular Diagnostics in Point of Care Product
Table 86. Bio-Rad Laboratories Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 87. Bio-Rad Laboratories Recent Development
Table 88. Bosch Healthcare Solutions Company Detail
Table 89. Bosch Healthcare Solutions Business Overview
Table 90. Bosch Healthcare Solutions Molecular Diagnostics in Point of Care Product
Table 91. Bosch Healthcare Solutions Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 92. Bosch Healthcare Solutions Recent Development
Table 93. Curetis Company Detail
Table 94. Curetis Business Overview
Table 95. Curetis Molecular Diagnostics in Point of CareProduct
Table 96. Curetis Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 97. Curetis Recent Development
Table 98. Eurofins Scientific Company Detail
Table 99. Eurofins Scientific Business Overview
Table 100. Eurofins Scientific Molecular Diagnostics in Point of CareProduct
Table 101. Eurofins Scientific Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 102. Eurofins Scientific Recent Development
Table 103. Genetic Signatures Company Detail
Table 104. Genetic Signatures Business Overview
Table 105. Genetic Signatures Molecular Diagnostics in Point of CareProduct
Table 106. Genetic Signatures Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 107. Genetic Signatures Recent Development
Table 108. Grifols Company Detail
Table 109. Grifols Business Overview
Table 110. Grifols Molecular Diagnostics in Point of CareProduct
Table 111. Grifols Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 112. Grifols Recent Development
Table 113. Hibergene Diagnostics Company Detail
Table 114. Hibergene Diagnostics Business Overview
Table 115. Hibergene Diagnostics Molecular Diagnostics in Point of CareProduct
Table 116. Hibergene Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 117. Hibergene Diagnostics Recent Development
Table 118. Lumos Diagnostics Company Detail
Table 119. Lumos Diagnostics Business Overview
Table 120. Lumos Diagnostics Molecular Diagnostics in Point of CareProduct
Table 121. Lumos Diagnostics Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 122. Lumos Diagnostics Recent Development
Table 123. Roche Company Detail
Table 124. Roche Business Overview
Table 125. Roche Molecular Diagnostics in Point of CareProduct
Table 126. Roche Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 127. Roche Recent Development
Table 128. Siemens Company Detail
Table 129. Siemens Business Overview
Table 130. Siemens Molecular Diagnostics in Point of CareProduct
Table 131. Siemens Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 132. Siemens Recent Development
Table 133. Thermo Fisher Scientific Company Detail
Table 134. Thermo Fisher Scientific Business Overview
Table 135. Thermo Fisher Scientific Molecular Diagnostics in Point of CareProduct
Table 136. Thermo Fisher Scientific Revenue in Molecular Diagnostics in Point of Care Business (2017-2022) & (US$ Million)
Table 137. Thermo Fisher Scientific Recent Development
Table 138. Research Programs/Design for This Report
Table 139. Key Data Information from Secondary Sources
Table 140. Key Data Information from Primary Sources

List of Figure

List of Figures
Figure 1. Global Molecular Diagnostics in Point of Care Market Share by Type: 2021 VS 2028
Figure 2. Polymerase Chain Reaction Features
Figure 3. In Situ Hybridization Features
Figure 4. Gene Chips Features
Figure 5. Next Generation Sequencing Features
Figure 6. Global Molecular Diagnostics in Point of Care Market Share by Application in 2021 & 2028
Figure 7. Hospitals and Clinics Case Studies
Figure 8. Independent Clinical Laboratories Case Studies
Figure 9. Molecular Diagnostics in Point of Care Report Years Considered
Figure 10. Global Molecular Diagnostics in Point of Care Market Size (US$ Million), Year-over-Year: 2017-2028
Figure 11. Global Molecular Diagnostics in Point of Care Market Size, (US$ Million), 2017 VS 2021 VS 2028
Figure 12. Global Molecular Diagnostics in Point of Care Market Share by Region: 2021 VS 2028
Figure 13. Global Molecular Diagnostics in Point of Care Market Share by Players in 2021
Figure 14. Global Top Molecular Diagnostics in Point of Care Players by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Molecular Diagnostics in Point of Care as of 2021)
Figure 15. The Top 10 and 5 Players Market Share by Molecular Diagnostics in Point of Care Revenue in 2021
Figure 16. North America Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 17. North America Molecular Diagnostics in Point of Care Market Share by Country (2017-2028)
Figure 18. United States Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 19. Canada Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 20. Europe Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 21. Europe Molecular Diagnostics in Point of Care Market Share by Country (2017-2028)
Figure 22. Germany Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 23. France Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 24. U.K. Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 25. Italy Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 26. Russia Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 27. Nordic Countries Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 28. Asia-Pacific Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 29. Asia-Pacific Molecular Diagnostics in Point of Care Market Share by Region (2017-2028)
Figure 30. China Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 31. Japan Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 32. South Korea Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 33. Southeast Asia Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 34. India Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 35. Australia Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 36. Latin America Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 37. Latin America Molecular Diagnostics in Point of Care Market Share by Country (2017-2028)
Figure 38. Mexico Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 39. Brazil Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 40. Middle East & Africa Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 41. Middle East & Africa Molecular Diagnostics in Point of Care Market Share by Country (2017-2028)
Figure 42. Turkey Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 43. Saudi Arabia Molecular Diagnostics in Point of Care Market Size YoY Growth (2017-2028) & (US$ Million)
Figure 44. Abbott Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 45. Accelerate Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 46. Ador Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 47. Beckman Coulter Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 48. Becton, Dickinson and Company Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 49. Binx Health Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 50. Biocartis Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 51. bioM?(C)rieux Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 52. Bio-Rad Laboratories Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 53. Bosch Healthcare Solutions Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 54. Curetis Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 55. Eurofins Scientific Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 56. Genetic Signatures Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 57. Grifols Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 58. Hibergene Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 59. Lumos Diagnostics Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 60. Roche Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 61. Siemens Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 62. Thermo Fisher Scientific Revenue Growth Rate in Molecular Diagnostics in Point of Care Business (2017-2022)
Figure 63. Bottom-up and Top-down Approaches for This Report
Figure 64. Data Triangulation
Figure 65. Key Executives Interviewed